AML/MDS
Oncology·MeSH: Leukemia, Myeloid, Acute
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| senti-202 | Senti Biosciences, Inc. (SNTI) |
Frequently asked questions
How many drugs are in development for AML/MDS?
BioSniper tracks 1 drug in development for AML/MDS across 1 company.
How many clinical trials target AML/MDS?
There are 1 clinical trial targeting AML/MDS tracked by BioSniper.
Deep-dive into AML/MDS
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis